Piramal Pharma Sees Surge in Open Interest Amid Increased Trading Activity
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 7,163 contracts, alongside a trading volume of 4,089 contracts. The stock is currently 4.9% above its 52-week low and has outperformed its sector. Despite a slight decline in delivery volume, it maintains significant liquidity.
Piramal Pharma Ltd (PPLPHARMA) has experienced a significant increase in open interest today, reflecting notable activity in the stock. The latest open interest stands at 7,163 contracts, up from the previous 6,061 contracts, marking a change of 1,102 contracts or an 18.18% increase. The trading volume for the day reached 4,089 contracts, contributing to a futures value of approximately Rs 4,536.17 lakhs and an options value of Rs 1,579.57 crores, bringing the total value to Rs 4,947.59 lakhs.In terms of price performance, Piramal Pharma is currently 4.9% away from its 52-week low of Rs 181.73. The stock has outperformed its sector by 2.03%, with an intraday high of Rs 191.42, reflecting a gain of 2.52% for the day. The weighted average price indicates that more volume was traded closer to the low price, while the stock's moving averages show it is above the 5-day and 20-day averages but below the 50-day, 100-day, and 200-day averages.
Despite a decline in delivery volume by 3.1% against the 5-day average, the stock remains liquid enough for trades of Rs 0.84 crore, with a market capitalization of Rs 24,830 crores in the small-cap segment. Overall, the increase in open interest highlights a shift in market dynamics for Piramal Pharma, underscoring the stock's current activity without delving into future implications.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
